Growth Metrics

Whitehawk Therapeutics (WHWK) Receivables - Net: 2020-2024

Historic Receivables - Net for Whitehawk Therapeutics (WHWK) over the last 3 years, with Dec 2024 value amounting to $5.9 million.

  • Whitehawk Therapeutics' Receivables - Net rose 7.56% to $5.9 million in Q4 2024 from the same period last year, while for Dec 2024 it was $5.9 million, marking a year-over-year increase of 7.56%. This contributed to the annual value of $5.9 million for FY2024, which is 7.56% up from last year.
  • Latest data reveals that Whitehawk Therapeutics reported Receivables - Net of $5.9 million as of Q4 2024, which was down 9.74% from $6.5 million recorded in Q3 2024.
  • Whitehawk Therapeutics' Receivables - Net's 5-year high stood at $14.1 million during Q4 2020, with a 5-year trough of $1.9 million in Q4 2022.
  • For the 3-year period, Whitehawk Therapeutics' Receivables - Net averaged around $4.4 million, with its median value being $5.2 million (2023).
  • Per our database at Business Quant, Whitehawk Therapeutics' Receivables - Net spiked by 194.74% in 2023 and then fell by 11.36% in 2024.
  • Quarterly analysis of 4 years shows Whitehawk Therapeutics' Receivables - Net stood at $14.1 million in 2020, then reached $1.9 million in 2022, then skyrocketed by 194.74% to $5.5 million in 2023, then grew by 7.56% to $5.9 million in 2024.
  • Its last three reported values are $5.9 million in Q4 2024, $6.5 million for Q3 2024, and $5.9 million during Q2 2024.